Hartford Hospital

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Hartford Hospital sits in the top decile of US sponsors by registered trial count (#290 of 15,742 sponsors by registered trial count).

75 total trials 8 currently recruiting 56 completed top decile by trial count

Hartford Hospital: 75 sponsored US clinical trials, 8 recruiting.

Hartford Hospital sponsors 75 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 56 completed. 15 of these trials are in Phase 3-4 (later-stage) and 17 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 3 trials.

Top-decile sponsor footprint

Hartford Hospital ranks in the top decile of sponsors by registered trial count (#290 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

56 of 61 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

75 total, page 2 of 2

COMPLETED Phase 2

Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity

NCT02667015

COMPLETED Early Phase 1

Cognitive Remediation for Neuropsychological Impairment in Compulsive Hoarding

NCT01451697

COMPLETED NA

A Lifestyle Intervention for Breast Cancer Survivors

NCT01819324

COMPLETED NA

The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot

NCT01480336

COMPLETED Phase 2

Entereg Laparoscopic Colon Resection Study

NCT01258569

COMPLETED Phase 4

Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion

NCT01148771

COMPLETED NA

Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics

NCT01450306

TERMINATED Phase 4

Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse

NCT01092624

COMPLETED NA

Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging

NCT01021618

COMPLETED Phase 3

Effect of Working Memory Training on ADHD Brain Function

NCT02151396

COMPLETED NA

Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy

NCT00888979

COMPLETED Phase 1

Changes in Biomarkers Using Prostaglandin Inhibitors

NCT01769625

COMPLETED Phase 4

Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation

NCT00519337

COMPLETED Phase 1

Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors

NCT01425476

COMPLETED Phase 2

The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly

NCT01361633

COMPLETED Phase 2

The Use of SennaS for Prevention of Post-operative Constipation After Urogynecologic Surgery

NCT00571896

COMPLETED NA

The Effect of Statin Medications on Muscle Performance (The STOMP Study)

NCT00609063

COMPLETED NA

Stepped Care for Treating Obsessive-Compulsive Disorder

NCT00316355

COMPLETED Phase 4

The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control

NCT00282659

COMPLETED NA

Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty

NCT01114646

COMPLETED

Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT

NCT01179230

COMPLETED NA

Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder

NCT00131339

COMPLETED

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

NCT00282711

COMPLETED

Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to Psychostimulants

NCT01310439

COMPLETED NA

Treatment Response to Rehabilitation in Patients With Schizophrenia

NCT00063336

← Previous Page 2 of 2

What is open in the Hartford Hospital pipeline

8 recruiting of 75 indexed (11% open); 56 completed (75%).

Phase mix: 15 late (III/IV) vs 17 early (I/II) (balanced across stages).

Top condition: Obesity (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Hartford Hospital: open-pipeline peers nationwide

Peers matched on 75 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

Hartford Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200 0%10%20%30%40% Total trials Recruiting share Hartford HospitalC. R. BardECOG-ACRIN Cancer Research GroupInova Health Care ServicesIonis PharmaceuticalsUConn HealthTufts Medical CenterCAMC Health SystemBastyr University
Hartford Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Hartford Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 75 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this Hartford Hospital page

75 registered trials is a research-attention snapshot, not an endorsement of Hartford Hospital or any single study.

  • 8 of Hartford Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Hartford Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Hartford Hospital pipeline card: 75 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.